November 24, 2021 10:52 am
The company completed large-scale enrolment of its phase-3 clinical trials by early February in in patients with chronic kidney disease, both on dialysis and not on dialysis.
August 27, 2021 7:17 am
The Drug Controller General of India recently approved phase 2/3 study protocols of HGCO19, developed by Gennova Biopharmaceuticals Limited, a subsidiary of Pune-based Emcure Pharmaceuticals Limited.
May 17, 2019 1:51 am
According to a notification issued on Thursday by the CDSCO, the practice of changing the key therapeutic ingredients in a drug formulation without changing the brand name “is not only misleading but may also result in undesirable pharmacological effects as the consumer would take the formulation assuming that it has the earlier composition.”
June 19, 2018 2:17 am
This mechanism will be implemented across India on a trial basis to spot out counterfeit drugs.
June 21, 2017 12:05 am
Move to replace gelatin-based capsules with those made from plant products is not guided by medical reasons.
March 04, 2014 1:56 am
Drug controller post vacant since 2006, 11 drug inspector posts have become vacant in last three years
January 29, 2014 2:45 am
Move comes soon after US Food and Drug Administration (USFDA) banned Ranbaxy’s fourth unit at Toansa.
January 28, 2014 5:25 am
While Ranbaxy products cannot be sold in the US, the same drugs continue to be sold in India as standards applied by regulators in the two countries differ.
December 06, 2013 1:02 am
The Punjab and Haryana High Court Thursday dismissed a petition filed by the Chandigarh Chemists Associated (CCA).
November 29, 2013 4:31 am
A birthday party in the state gave Congress leaders an opportunity to come down heavily on Chief Minister Narendra Modi.